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Activation-induced deaminase (AID) mediates the somatic hyper-
mutation (SHM) of Ig variable (V) regions that is required for the
affinity maturation of the antibody response. An intensive anal-
ysis of a published database of somatic hypermutations that arose
in the IGHV3-23*01 human V region expressed in vivo by human
memory B cells revealed that the focus of mutations in comple-
mentary determining region (CDR)1 and CDR2 coincided with
a combination of overlapping AGCT hotspots, the absence of
AID cold spots, and an abundance of polymerase eta hotspots. If
the overlapping hotspots in the CDR1 or CDR2 did not undergo
mutation, the frequency of mutations throughout the V region
was reduced. To model this result, we examined the mutation of
the human IGHV3-23*01 biochemically and in the endogenous
heavy chain locus of Ramos B cells. Deep sequencing revealed that
IGHV3-23*01 in Ramos cells accumulates AID-induced mutations pri-
marily in the AGCT in CDR2, which was also the most frequent site
of mutation in vivo. Replacing the overlapping hotspots in CDR1
and CDR2 with neutral or cold motifs resulted in a reduction in
mutations within the modified motifs and, to some degree,
throughout the V region. In addition, some of the overlapping
hotspots in the CDRs were at sites in which replacement muta-
tions could change the structure of the CDR loops. Our analysis
suggests that the local sequence environment of the V region, and
especially of the CDR1 and CDR2, is highly evolved to recruit muta-
tions to key residues in the CDRs of the IgV region.
AID | cytosine deamination | complementarity-determining regions |
somatic hypermutation | IGHV3-23
After an encounter with antigen and subsequent migrationinto the germinal centers of the secondary lymphoid organs,
B cells undergo a regulated cascade of mutational events that
occur at a very high frequency and are largely restricted to the
variable (V) and switch (S) regions of the Ig heavy chain locus
and the V region of the light chain locus. These mutagenic events
are responsible for the somatic hypermutation (SHM) of the V
regions and the class switch recombination of the constant (C)
regions that are required for protective antibodies (1, 2). Both
SHM and class switch recombination are initiated by activation-
induced deaminase (AID) that preferentially deaminates the dC
residues in WRC (W = A/T, R = A/G) hotspot motifs at fre-
quencies 2–10-fold higher than SYC (S = G/C; Y = C/T) cold
spots (3–7). During V region SHM, the resulting dU:G mismatch
can then be replicated during S-phase to produce transition
mutations, be processed by uracil-DNA glycosylase 2 and apurinic/
apyrimidinic endonucleases through the base excision repair
pathway to produce both transitions and transversions (8–10), or
be recognized by MutS homolog (MSH)2/MSH6 of the mismatch
repair (MMR) complex that recruits the low-fidelity polymerase
eta (Polη) to generate additional mutations at neighboring A:T
residues (11).
The specificity of AID targeting to the Ig gene has been under
intense investigation. Studies have shown that AID deamination
and mutagenesis targets single-stranded DNA substrates gener-
ated during transcription (12, 13). Transcription-associated pro-
teins and RNA processing factors also participate in the AID
mutational process and, in some cases, physically interact with
AID (14–17). In addition, other transacting proteins (18, 19), in-
cluding chaperones (20), chromatin modifiers and remodelers (21–
23), cell cycle regulators (24), developmental factors (25), and cis-
acting sequences (26, 27), appear to affect mutations. However, all
of these factors also have pleiotropic effects on non-Ig genes in B
cells, so they do not appear to be solely responsible for the tar-
geting of AID-induced mutations to the Ig V. Because many non-
Ig genes are also highly transcribed in activated B cells and AID
appears to occupy many sites in such cells (28, 29) and can also
cause mutations in non-B cells, it is important to understand why
the very high rate of mutation in the SHM is not seen in other
highly expressed genes in B cells. In addition, we are still learning
about how the V regions can undergo such high rates of mutation
and still assemble their heavy and light chain V regions to produce
a stable antigen-binding site that can undergo affinity maturation
and changes in fine specificity. Although it is clear that mutations
in the complementary determining regions (CDRs) play a critical
role in antigen binding, recent studies reveal that some of these
highly mutated sites in the CDRs do not directly interact with
antigen but have an important role in generating protective
broadly neutralizing antibodies to influenza and HIV (1, 30, 31).
Taken together, these findings suggest that the DNA sequence of
Ig V regions has evolved so that AID will mutate certain subregions
while protecting those parts of the V region that are required to
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maintain the overall structure and function of the protein (32). This
evolutionary process is reflected in the fact that codons used in the
CDRs are more likely to create AID hotspots and to result in
replacement mutations than the codons used in the frameworks
(FWs) (7, 32, 33). There is the potential for an even more in-
tricate process (32), as hotspots for AID can assume a variety of
sequences, each undergoing mutations at different frequencies
(6, 7, 34). Particularly interesting is the WGCW motif, which
provides two overlapping WRC motifs on opposing strands of
the DNA (3, 5, 7). These overlapping AID hotspots can have
very high rates of mutation in the V and S regions (3, 7, 35–39),
but it is unclear whether they influence the global mutation
pattern of the whole V region.
To examine this, we have studied the frequency and distri-
bution of mutations in IGVH3-23*01. The IGVH3 family rep-
resents about half of the functional genomic human V regions
(40), and IGVH3-23 is particularly interesting because it is the
most commonly used V region during normal immune responses
(41–43), as well as in some B-cell malignancies (44). Fortunately,
there is a large database available for bioinformatic analysis with
independently mutated productive and nonproductive human
IGHV3-23*01 sequences (45, 46). By analyzing the patterns of
mutation in the nonproductive genes in this memory B-cell
database, we found that the overlapping AID hotspot (OHS),
WGCW, especially AGCT, has a marked propensity to undergo
AID deamination, especially in CDR2 of human IGHV3-23*01,
and that if the OHS in CDRs do not undergo mutation, there is
a decrease in the mutation frequency throughout the V region.
We used a biochemical assay and the Ramos cell line where we
could modify some of the AGCTs in the CDR1 and CDR2 by
site-directed mutagenesis to analyze their relative susceptibility
to mutation and found that there is a significant decrease not
only in the frequency of mutation in the overlapping hotspots
but also throughout the V region, when this motif was removed
from the CDRs. These findings suggest that additional levels of
complexity exist in the sequence of the V region that facilitate
the generation of highly protective antibodies.
Results
Overlapping Hotspots in Human IGHV3-23*01 Accumulate High Frequencies
of Mutation in Vivo.To assess the role of the local sequence context
in recruiting AID-induced mutations in human heavy chain V
regions, we first reexamined the relative frequency and distri-
bution of 2,657 independent mutations in IGHV3-23*01 V
regions from circulating memory B cells of 24 normal indi-
viduals reported by Ohm-Laursen and colleagues (45, 46).
These mutations were from 438 V regions that had premature
stop codons or frame shifts that likely arose during the crea-
tion of the CDR3 and were extracted by Ohm-Laursen and
colleagues (45, 46) from a larger database of IGHV3-23*01 V
region sequences. Because the mutations were at sites of variable,
diversity, and joining (VDJ) region rearrangement, the V regions
are presumed to have been nonproductive throughout the dif-
ferentiation of the B-cell clone that contained them, so the sub-
sequent mutations that arose in those V regions were not subjected
to antigen selection (45, 46). Because none of the V regions shared
the same CDR3, the observed mutations arose from different
B-cell clones, and each of these nonproductive V regions
reflects sets of independent mutational events (45, 46). The
upper panel of Fig. 1 shows the frequency of mutations that
accumulated at each position. The black vertical lines are
mutations in dC on either strand and are presumed to have
been initiated by the direct action of AID, whereas the gray
vertical lines are mutations in A:T residues and are presumed
be a result of error-prone MMR (47). After recent precedents
(1, 30, 48), the CDRs indicated by the horizontal gray bars at
the top of the figure are based on the Kabat criteria (49) combined
with analysis of the crystal structure of the IGHV3-23*01V region,
rather than the IMGT definition (48). It is obvious that the fre-
quency of these independent and unique somatic mutations in
Fig. 1. Demonstration of the mutation distribution of IGHV3-23*01 in vivo. The database includes V regions that are mutated (264) and not mutated (174).
Each CDR3 was unique; they are not shown here. The x axis shows the mutation sites within the V region. The y axis is the mutation frequency for each site.
Black lines show the mutation frequencies that occurred at G:C sites. Gray lines demonstrate the mutation frequencies at A:T sites. Each colored dot in the
bottom panels represents an AID hot/cold/neutral spot or Polη hotspot, as labeled at both edges. Double dots are AID overlapping hotspots (WGCW) or two
adjacent Polη hotspots. The red arrows point to the OHS1 and OHS2 overlapping hotspots, as labeled. Horizontal gray bars on top are CDRs as labeled.
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AID hotspots, including the overlapping hotspots, differed greatly
at different sites throughout the V region, with some of the higher
frequencies occurring in CDR1 and CDR2 (Fig. 1).
Characteristics of AID Hotspot Motifs and Broader Sequence
Requirements. At least some of the reasons for these different
frequencies of mutation became obvious when we examined the
motifs that were associated with the mutations. These are an-
notated in the lower horizontal panels of Fig. 1, where the dif-
ferent motifs displayed at the edges of each panel are represented
by colored dots to indicate where they are located within the V
region sequence. For example, the first horizontal bar in the lower
panel shows a red dot at residue 149, representing the C in the
AGCT hotspot motif on the upper strand and an adjacent red
dot representing the C at residue 148 in the 3′-TCGA-5′ AID
hotspot on the lower strand. This overlapping AGCT hotspot in
CDR2 (OHS2 marked by the arrow) has accumulated approx-
imately two times as many mutations as each of the two AGCT
overlapping hotspots in CDR1 (both P values are less than 10−6
in χ2 test), and almost three times as many mutations as there
are in the AGCT at residues 9 and 10 in FW1 (P < 10−6). The
AGCTs in CDR1 and CDR2 have more mutations than the AGCA
in each of those CDRs. The AGCT in the middle of CDR1
(OHS1 marked by an arrow in Fig. 1) is also part of an adjoining
AGCA overlapping hotspot (AGCAGCT) on the same strand,
resulting in a tight cluster of four hotspots on the two strands
(Fig. 1 and Fig. S1).
The relatively high frequency of mutations in OHS2 and in
other G:C and A:T bases in CDR2 and of G:Cs in other sites
such as around residue 280 in FW3 suggest that some neigh-
boring sequences could be contributing to the high frequency of
mutation of certain parts of the V regions. It is particularly in-
teresting that CDR1 and CDR2 are relatively devoid of AID
cold spots (SYC and GRS, where R =A/G, S =G/C and Y = C/T)
and are rich in AID hotspots (Fig. 1). Overall, there is a statis-
tically significant enrichment of hotspots in CDRs versus FWs
(Fig. S2A; Fisher test, P = 7 × 10−4). Approximately 50% of the
G:C bases in CDR1 and CDR2 are in AID hotspots (Fig. S2A),
and CDR1 has 15% of the remaining G:C bases in cold spots;
there are no cold spots in CDR2. In contrast, less than 22% of
the G:C bases in the FWs are in AID hotspots. In addition,
there are more WA Polη hotspots in CDR1 and CDR2 than
in FW1 and FW2. Approximately 45% of the A:T residues in
CDR1 and CDR2 are in Polη hotspots, and most of these are
in TA motifs, which are more susceptible to errors (50–52),
whereas in FW1 and FW2, the percentage of A:T residues that
are in TA motifs is much lower (Fig. S2B). Again, this difference
is significant (P = 6.5 × 10−3). The clusters of TA Polη hotspots
in CDR2 and, to a lesser extent, in CDR1 are associated with
many Polη mutations. FW3 has as many Polη mutations as
CDR1, but most of them are in AA motifs, which is very in-
frequent in the other parts of the V region (Fig. 1 and Fig. S2B).
This nonrandom distribution of motifs and the frequency of
associated mutations suggest that the overall sequence context,
as well as specific motifs, is important in targeting AID and
Polη mutations.
Association of Mutations in the OHS1 and OHS2 with Mutations
Throughout the V Region. Because the relative frequency of mu-
tation in OHS2 and, to a lesser degree, in the other overlapping
hotspots is so high, it is possible that those mutations serve as an
activation or entry site for AID mutations of the whole V region.
To address whether the presence or absence of mutations in the
overlapping hotspots is associated with differences in the char-
acteristics or distribution of mutations elsewhere in the V region,
we compared the mutations per V region and the overall mu-
tation frequency in V regions that did and did not have muta-
tions in each of the overlapping AGCT AID hotspots (Fig. 2). To
focus on the mutations in the rest of V region, we subtracted the
mutations that had occurred in the GC bases of that particular
AGCT. As shown in Fig. 2A, in those V regions where OHS2 was
mutated on both or either strand (OHS2 mutated), there were
many more mutations elsewhere in those V regions than in V
regions that did not have any mutations in OHS2 (13 vs. 4). This
was associated with a significantly higher overall frequency of
mutations throughout the V region in which OHS2 had un-
dergone mutation compared with those V regions in which
OHS2 is not mutated (4.5 × 102 vs. 1.5 × 102 mutations/bp; P <
10−6). This decrease is reflected by the mutations at both G:C
and A:T bases throughout the whole V region (Fig. 3). This
would be expected because most of the mutations in A:T are the
result of the recruitment of error-prone mismatch repair by the
Analyzed V regions
 (mutated V regions)
157 107
Average mutation 
Number per V
13 4
Overall frequency 4.5x10-2 1.5x10-2
OHS2 
mutated
OHS2 
unmutated
A B
C
Analyzed V regions
(mutated V regions)
85 179
Average mutation 
Number per V 16 7
Overall frequency 5.5x10-2 2.4x10-2
104/105 
mutated
104/105 
unmutated
Analyzed V regions
(mutated V regions)
65 199
Average mutation 
Number per V
15 8
Overall frequency 5.4x10-2 2.8x10-2
9/10 
mutated
9/10 
unmutated
D
Analyzed V regions
(mutated V regions)
85 179
Average mutation 
Number per V
15 7
Overall frequency 5.3x10-2 2.5x10-2
OHS1 
mutated
OHS1 
unmutated
Fig. 2. Analysis of the mutations in subsets of the memory B-cell database. (A) Analysis of OHS2 mutated and unmutated V regions. The first subset in the
first column is the V regions that have both GC in OHS2 mutated or either G or C mutated (shown in the arrow in Fig.1). The second column is the V regions
that have no mutations at either G or C in OHS2 and one or more additional mutations. The mutation frequencies do not include the mutations that occurred
at the GC sites in OHS2, so that only the mutations outside of those GC sites are compared. The bolded number represents the frequency of mutation in V
regions in which neither G nor C of OHS2 was mutated and represents a significantly decreased frequency of mutation compared with those V regions in
which G or C of OHS2 or both GC were mutated [P < 10−6, calculated in SHMTool program in which the χ2 test is implemented (76)]. (B) Analysis of OHS1
mutated and unmutated V regions. (C) Analysis of 104/105 GC in CDR1 mutated and unmutated V regions. (D) Analysis of 9/10 GC sites in FW1 mutated and
unmutated V regions. In B, C, and D, the same analysis was performed as in A, and the bolded values are significantly decreased (P < 10−6).
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G:U mismatch created by AID. Even though there were many
fewer mutations throughout the V region in those Vs that did not
undergo mutation in OHS2 (Fig. 2A), the spatial distribution of
mutations, excluding OHS2 itself, is similar (Pearson correlation
of site-by-site mutation frequencies, r = 0.70; P < 10−6). In
particular, the absence of mutations in OHS2 was associated
with fewer mutations in OHS1, as well as in the AGCTs at the
other overlapping hotspots in FW1 and at the 3′ end of CDR1
(Fig. 3). The effect of the mutations in overlapping hotspots in
OHS1 (arrow in Fig. 1) was similar to that of OHS2 (Fig. 2B),
with a statistically significant decrease in the overall frequency of
mutation elsewhere in the V region, as well as fewer mutations/
V regions.
The decrease in mutations throughout the IGHV3-23*01 V
region associated with the lack of mutation in OHS1 and in
OHS2 suggested that OHS1 and OHS2 might serve as activation
or entry sites for AID to initiate the process of SHM in a par-
ticular V region. However, these were purely correlations, and it
is difficult to imagine how an AID-induced mutation at one dC
in the V region would influence the frequency of mutations at
distant dCs, as it appears that most of the time there is only one
AID-induced mutation during each cell cycle (53–55). This
raised the alternative possibility that the results described in Figs.
2 A and B and 3 are the result of AID mutation being a stochastic
process, in which the frequency at each site reflects the suscep-
tibility of that site to AID deamination. To examine these two
different hypotheses further, we determined whether mutations
in the other AGCTs in IGHV3-23*01 were associated with
changes in the frequency of mutation elsewhere in those V
regions. The GC sites in the AGCT motif at residues 104 and 105
in the 3′ end of CDR1 (Fig. 1 and Fig. S1) were as highly mu-
tated as OHS1. As with OHS1 and OHS2, the lack of mutations
of the C on either strand in the AGCT 104/105 was associated
with a decrease in mutation throughout the V region (Fig. 2C).
We also examined the AGCT at residues 9 and 10 in FW1 (Fig. 1
and Fig. S1). This site is preceded by a TGCA overlapping
hotspot, but there are very few mutations in either G or C of
TGCAs in IGHV3-23*01 (Fig. 1). As can be seen in Fig. 2D, the
lack of mutations in the AGCT in residues 9 and 10 in FW1 was,
as with OHS1 and OHS2, associated with a significantly lower
frequency of mutations throughout the rest of the V region.
The finding that the lack of mutation at each of the AGCTs
was correlated with a similar decrease in the frequency of
mutation throughout the V regions made it less likely that the
AGCTs in CDR1 and CDR2 were routinely acting as the ac-
tivation or entry site for the whole V region. Rather, these find-
ings suggested that the frequency of mutations at each of the
AGCTs was largely the result of a stochastic process that
reflected their inherent susceptibility to AID and the overall
mutational state of that particular B cell at the time that mu-
tation was occurring. Nevertheless, it was quite possible that
on some occasions, the initial mutation, for example, at OHS2
did act as an entry or activation site for subsequent mutations
in that V region. We therefore set out to further evaluate the
role of the overlapping AGCT hotspot in the V region muta-
genesis process experimentally.
OHS Targeting in Vitro. Because the substrate for AID in vivo is
ssDNA (12), we used a biochemical system to compare the
ability of purified AID to mutate the germ line IGHV3-23*01
WT gene (3-23WT) and a variant IGHV3-23*01 modified gene
(3-23Mod) in which OHS1 and OHS2 and their immediate sur-
rounding sequences had been modified to replace the over-
lapping hotspot motifs with neutral and cold spots (Fig. 4A). We
focused on OHS2 because it was the most mutated AGCT in
IGHV3-23*01 in unselected memory B cells, and the V regions
that did not undergo mutation at that site had the fewest muta-
tions elsewhere in the V region (Figs. 2 and 3). We also modified
the AGCT in OHS1 because it and OHS2 were embedded in the
same CAGCTAT motif that occurs only at these two sites in
Fig. 3. Comparison of the two subsets of the memory B-cell database. (Top)
V regions that have mutations in both or neither CDR2 overlapping hotspots
mutated (OHS2 mutated). (Bottom) V regions in which neither strand of
OHS2 is mutated (OHS2 unmutated) and the V regions have mutations at
other sites. The red arrows point to OHS1 and OHS2. The gray bars on top
are the CDRs as labeled. The vertical black lines show the frequency of
mutations at G:C sites, and the vertical gray lines show the frequency of
mutations at A:T sites. The x axis shows the position of each of the muta-
tions. The y axis shows the mutation frequency.
 Analyzed V regions 42 43 P value 39 40 P value
Mutated V regions 100% 100% 100% 100%
Average mutation
number per V 6 5 15 12
Overall frequency 1.6 x10-2 1.3 x10-2 0.036 4.1 x10-2 3.2 x10-2 2.7x10-5
Frequency in 
unmodified region 1.4x10
-2 1.3x10-2 0.63 3.8x10-2 3.2x10-2 0.009
          1min
3-23WT 3-23Mod
5min
3-23WT 3-23Mod
AGCAGCT3-23WT
CDR1
AGCTATTAGT
CDR2
TCGTCTT3-23Mod GATTATTTCG
A
B
Fig. 4. In vitro analysis. (A) DNA modification schematic in which 3-23WT is
the IGHV3-23*01 WT germ line DNA sequence and 3-23Mod shows the
modified IGHV3-23*01 DNA sequence. The highlighted nucleotides in red
are the AGCT sites in CDR1 and CDR2. The bold nucleotides are the differ-
ences between 3-23WT and 3-23Mod DNAs. The 6-bp AGCAGC in CDR1 of
3-23WT are changed to TCGTCT in 3-23Mod, and another 6-bp AGC...AGC in
CDR2 of 3-23WT are changed to GAT...TCG in 3-23Mod. The light blue boxes
mark the CDRs as labeled but are not drawn to scale. (B) Mutation frequency
generated by the in vitro assay. This table shows the untranscribed (Top)
strand DNAmutation frequencies after 1- and 5-min incubations with AID, as
labeled on the top of the table. The first row shows the number of V regions
sequenced, and the second row tells the percentage of the mutated V
regions in the number of the first row. “Average mutation number per V”
shows the total mutations divided by number of mutated V regions. “Overall
frequency” shows the total mutation frequencies in all of the V regions
shown in the first row (mutations/bp). “Frequency in unmodified region”
refers to the mutation frequency in the V region excluding the modified
area. P values are shown after each comparison between 3-23WT and
3-23Mod and calculated in SHMTool, as described in ref. 76. The bold numbers
show the significantly decreased values in 3-23Mod compared with 3-23WT.
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IGHV3-23*01, and the lack of mutation in OHS1 was also asso-
ciated with a decrease in mutation elsewhere in the V region (Fig.
2B). The 6 bp that were changed in CDR1 and the six different
changes that spanned a 10-bp stretch in CDR2 preserved most of
the amino acid sequence. These changes were made because the
same modified V region was going to be used in Ramos cell (see
following), and we wanted the IgM antibody to continue to be
expressed on the Ramos cell surface.
As shown in Fig. 4, when the top strand of the 3-23WT (Fig.
4B) and modified IGHV3-23*01 genes (3-23Mod) were in-
cubated with purified AID (6) for 1 min, there was a trend to-
ward fewer mutations in Cs in the modified V regions, but this
difference was only marginally significant (P = 0.036). However,
this difference was more focused on the overlapping hotspots
because the other parts of the V showed no difference (“Fre-
quency in unmodified region” in Fig. 4B; P = 0.63). After 5 min
of exposure to AID, there were significantly more mutations in
the 3-23WT than 3-23Mod (P < 0.001). This difference was seen
not only in the frequency of mutation throughout the V region,
including the overlapping hotspots, but also when the mutations
in OHS1 and OHS2 and their surrounding sequences in the WT
and the modified samples were removed from the calculation
and only the rest of the V region (unmodified region) was con-
sidered (Fig. 4B). There were no significant differences at either
1 or 5 min when ssDNA representing the bottom strand was
incubated with AID. Others have also seen differences between
biochemical studies of the top (untranscribed) and bottom
(transcribed) strands and attributed these to the fact that the in
vivo bottom strand is heavily occupied by RNA polymerase and
its many associated factors, including exosomes, so it is more
difficult to duplicate the process biochemically (14, 51). Because
AID is limited and processive through a slide-and-jump mech-
anism in this biochemical assay (56, 57), these results suggest that
even on single-stranded DNA, the AGCT motifs were more
likely to undergo AID-induced deamination and, through AID’s
processivity in this in vitro system, increase the frequency of
mutation throughout the V region.
The Lack of the OHSs Decreases the Mutation Frequency in Ramos
Cells. The analysis of the unselected Ohm-Laursen (46) memory
B-cell data (Figs. 1 and 2) revealed that the deamination of the
Cs in OHS2 was associated with different frequencies of muta-
tion in other parts of the V region. However, because in the
memory B-cell database there are multiple mutations in each V
region, and each of the V regions comes from a clonally different
memory B cell that has undergone many rounds of mutation, it is
difficult to deduce the order of the mutational events. In an at-
tempt to identify the location of the initial deaminations and the
effect of those events on the rest of the V region, we examined
mutations of the same germ line IGHV3-23*01 in the Ramos
cultured human B-cell line that is like the unselected memory
B-cell database and does not undergo antigen selection. We used
recombinase-mediated cassette exchange (RMCE) (38, 58) to
introduce the WT IGHV3-23*01 (3-23WT) and two modified
versions of IGHV3-23*01 (3-23Mod and 3-23AATT) as single
copies in the right orientation into the endogenous Ig heavy
chain V-region locus of the Ramos human Burkitt’s lymphoma
cell line (58). The Ramos cells are a germinal center-like B-cell
line that constitutively expresses AID at a low level (59) and
undergoes SHM at a rate that is 20–50 times lower than the
estimates for the rate of mutation in vivo (4, 58–60). After
RMCE replacement, cells were cultured for ∼3 mo. The inserted
germ line IGHV3-23*01 was sequenced by paired-end 250 ×
250-bp deep sequencing, using the Illumina MiSeq platform.
We combined the mutations from three subclones of one Ramos
clone transfected with the germ line IGHV3-23*01 (3-23WT)
and two subclones from another independently transfected
Ramos 3-23WT clone. Although the frequency of mutation in
Ramos was much lower than in vivo (see the different scales
in Ramos and memory B cell in Fig. 5), the distribution and
relative frequency of mutations in both G:C and A:T bases in the
various parts of the V region in vivo and the Ramos cell line were
quite similar (r = 0.66, Pearson correlation of site by site muta-
tion frequencies) and were even higher if we compare only the
mutations at G:C sites (r = 0.72) (Fig. 5). Nevertheless, there are
clear differences. The relatively highly mutated OHS1 in vivo has
relatively fewer mutations in Ramos, and the GC in the over-
lapping hotspot at residue 104 and 105 at the 3′ end of CDR1 has
relatively more mutations (Fig. 5). In addition, the AGCT at
residues 9 and 10 have more mutations than OHS1 and as many
as the AGCT at residues 104/105. As has been reported pre-
viously for the endogenous Ramos V region (58, 59), 90% of the
mutations were in G:C sites, and 10% were in A:T residues, most
of which were in Polη hotspots. This relatively lower frequency
of mutation in A:T residues in the Ramos cell line has been
reported by others (4, 58, 60). Consistent with this lower fre-
quency of mutations at A:T residues in Ramos, there are many
fewer mutations in the A:T residues just 3′ to OHS2 and at the 3′
end of the V region (Fig. 5) than are seen in vivo (Fig. 1). Be-
cause the OHS2 still had by far the most mutations in the Ramos
cell line expressing the WT IGHV3-23*01, and OHS1 was within
the same CAGCTAT context, we introduced the same modified
IGHV3-23*01 (3-23Mod) that we had used for the biochemical
experiments into the endogenous heavy chain locus in Ramos
cells (Fig. 6A).
As shown in Fig. 6B, using deep sequencing, we obtained
2,587,368 V region sequences in total and 715,886 mutated V
regions from a combination of five subclones of two independently
transfected Ramos clones expressing the 3-23WT V region, and
1,260,675 V regions in total and 76,977 mutated V regions from
a combination of five Ramos cell clones expressing the modified
IGHV3-23*01 (3-23Mod) V region in which OHS1 and OHS2
and their neighboring bases had been replaced (Fig. 6A). In the
WT Ramos IGHV3-23*01, 27.7% of the V regions were mutated,
Fig. 5. Comparison of the mutation pattern of IGHV3-23*01 in Ramos cell
lines (Ramos 3-23WT) with that from memory B-cell database (memory
B-cell). The y axis shows the mutation frequency. (Upper) Y axis is gapped from
0.012 to 0.098 and is a different scale than in the lower panel because of the
lower overall frequency of mutations and the relatively higher frequencies
in OHS2 in Ramos. CDRs are showed in the gray horizontal boxes. Black lines
and gray vertical bars represent G:C and A:T mutations frequencies, re-
spectively. Red arrows point to OHS1 and OHS2.
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whereas in the modified Ramos with the modified IgVH3-23*01,
only 16% of the Vs are mutated (Fig. 6B). This indicates that the
loss of OHS1 and OHS2 and their neighboring sequences resulted
in a 42% decrease in the number of V regions mutated (P <
0.001). Similarly, the loss of OHS1 and OHS2 and their neigh-
boring bases also resulted in a statistically significant (P < 10−6)
decrease in the overall frequency of mutation (16.4 × 10−4 vs.
5.8 × 10−4) (Fig. 6B). This decrease is largely a result of the loss
of mutations in the modified area of 3-23Mod, especially at the
OHS2 site, which is so highly mutated in 3-23WT (Fig. 6C).
However, there still is a significant decrease in mutation fre-
quency of 3-23Mod compared with 3-23WT when the mutations
in the modified region were subtracted from both the WT and
modified frequencies, so we could evaluate only the effect on
the other parts of the V region (“Frequency in unmodified re-
gion” in Fig. 6B). This suggests that in the Ramos cells, OHS1
and OHS2 and their surrounding sequences have an effect on
the mutations on the rest of the V region. It is important to note
that although the frequency of mutations outside the over-
lapping hotspots is relatively low in Ramos, as shown in Fig. 5,
there are many mutations distributed throughout the V region.
Because we only sequenced the V regions from clones in which
the mRNA and protein of AID were similar in the WT and
modified clones, this difference was not a result of differences in
AID abundance.
To examine the contribution of a single AGCT motif, as we
had done in Fig. 2A for OHS2 in vivo, we compared the effect of
changing only the GC sites in OHS2 in Ramos cells by creating
cells with a V region containing an AATT in place of the AGCT
in OHS2 (3-23AATT; Fig. 7A). We combined all of the se-
quences from four subclones of 3-23AATT and compared this
more restricted change to the same 3-23WT data shown in Fig. 6
because the experiments in Fig. 6 and Fig. 7 were all done in
parallel. The absence of only the Cs on both strands of OHS2
resulted in the same statistically significant decrease in the per-
centage of V regions that were mutated (P < 0.001) as when the
larger modifications were made in both CDR1 and CDR2 (Fig.
7B vs. Fig. 6B). This is because such a large percentage of the
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Fig. 6. DNA modification in both CDR1 and CDR2 changed the mutation
frequency of V region in Ramos. (A) DNA modification schematic is the same
as shown in Fig. 4A. (B) Mutation analysis in 3-23WT Ramos subclones and
DNA-modified Ramos subclones (3-23Mod). The first column has the values
from a pool of all of the V regions of five 3-23WT subclones, and the second
column contains the values from a pool of five 3-23Mod subclones. The first
row shows the numbers of the total V regions obtained from the deep se-
quencing for 3-23WT and 3-23Mod. In the parenthesis are the numbers of
mutated V regions. The second row has the percentages of mutated V
regions in total V regions shown in the first row. “Overall frequency” rep-
resents the mutations in all of the V regions (shown in the first row) that
occurred throughout the whole V region, including the mutations that oc-
curred in the modified regions, calculated in SHMTool (76). “Frequency in
unmodified region” shows the mutation rates after the mutations in the
modified area (12-bp differences totally in CDR1 and CDR2 between 3-23WT
and 3-23Mod) are excluded from 3-23WT and 3-23Mod V regions, and they
are also calculated in SHMTool. Bold values in 3-23Mod for mutation fre-
quencies are significantly decreased values compared with 3-23WT (P < 10−6,
calculated by SHMtool). The bold numbers are percentage of mutated V
regions, the P value is <0.001 (χ2 test). (C) Mutation distribution comparison
between 3-23WT and 3-23Mod. Upper part is 3-23WT, lower part is
3-23Mod, as labeled. The x axis gives the site for each mutation of V region.
The y axis shows the mutation frequency for each site. Each vertical line
represents the mutation frequency at the corresponding site, as labeled in
x axis. Red arrows point to OHS1 and OHS2.
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Fig. 7. DNA modification in OHS2 changed the mutation frequency in
Ramos. (A) DNA modification schematic: 3-23WT represents IGHV3-23*01
WT germ line DNA sequence, and 3-23AATT shows the GC sites of OHS2-
modified IGHV3-23*01 DNA sequence. The highlighted nucleotides are the
differences between 3-23WT and 3-23Mod. The light blue boxes mark the
CDRs as labeled. (B) Mutation analysis in V regions of 3-23WT and DNA
modified 3-23AATT subclones. The first column has the values obtained from
the same V regions as in Fig. 6B because the experiments in Figs. 6 and 7
were done in parallel. The second column contains the values from the
combination of the V regions from four 3-23AATT subclones. The rows
showed the numbers obtained by the same analysis as in Fig. 6B for
3-23AATT. Bold values in 3-23AATT for mutation frequencies are significantly
decreased values compared with 3-23WT (P < 10−6, calculated by SHMtool).
In the bold values for percentage of mutated V regions, the P value is <0.001
(χ2 test). Here the modified area only includes GC sites in OHS2. (C) Mutation
distribution comparison between 3-23WT and 3-23AATT. The upper part is
3–23WT, and the lower part is 3–23AATT. The rest is the same as described in
Fig. 6C. Red arrow points to OHS2.
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mutations in Ramos cells are in OHS2 (Fig. 7C). There is a ∼2.7-
fold decrease in the overall frequency of mutation in 3-23AATT
clones when the OHS2 is removed, which is the same as the
decrease in mutations when both OHS1 and OHS2 are removed
(Fig. 6). When the mutations in the modified sites were sub-
tracted, the mutation frequency in 3-23AATT was lower than
that in 3-23WT (“Frequency in unmodified region” in Fig. 7B).
We have carried out identical experiments on completely dif-
ferent Ramos subclones using 150 × 150 bp Illumina sequenc-
ing and obtained the same results. These differences between
3-23AATT and 3-23WT confirm that OHS2 plays a role in mu-
tating the whole V region.
Discussion
The Frequency and Distribution of Mutations in the IGHV3-23*01
V Region Is Associated with a Very Intricate Distribution of DNA
Sequence Motifs. We have explored the relationship of local se-
quence context to the frequency of AID-induced mutations in
the human IGHV3-23*01 in vivo, in vitro, and in Ramos B cells
to gain a better understanding of how the V region sequence has
evolved to generate antibody diversity and protective antibodies.
We selected IGHV3-23*01 because it is one of the most highly
used human V regions (41–43) and because a published database
(45, 46) had a large subset of mutated V regions that were
nonproductive and would reflect the inherent activity of AID
and its associated factors in the absence of antigen selection. The
most highly mutated sites in IGHV3-23*01 were overlapping
AGCT and AGCA hotspot motifs (46, 61), which are found in
CDR1 and CDR2 and at one location in the beginning of FW1
(Fig. 1). Mutations in the S regions are also focused on the
AGCT and AGCA (38). However, the overlapping characteristic
of these AID hotspot motifs alone is not sufficient to dictate the
mutation pattern in the V region because the AGCT (OHS2) at
the very 5′ end of CDR2 had a higher frequency of mutation
than the other AGCTs and AGCAs and the TGCA overlapping
hotspots were not highly mutated. This suggests that the broader
sequence environment must also be important. Our analysis (Fig.
1 and Fig. S2) also reveals that there is a paucity of SYC and
GRS cold spots and an increased abundance of AID hotspots
and TA Polη hotspots in CDR1 and CDR2. Although there are
many mutations in parts of FW3, the frequency is lower than in
the CDRs. For example, there are many mutations in A:T
around residue 280, where the A:Ts are between two simple AID
hotspots that mutate at an intermediate frequency, and as in the
CDR2, there are no AID cold spots. Mutations in FW3 have
been observed previously (62), and recent studies (1, 30) have
revealed the importance of mutations, and even deletions and
insertions, in the FWs in the broadly neutralizing capacity of
antibodies to HIV and influenza. In addition, it has been sug-
gested that mutations in the FW are necessary to stabilize the
structure of the CDRs (31). It is therefore quite likely that
evolution of antibody V regions has also generated sequence
contexts in the FWs that are more readily mutated and facilitate
the generation of protective antibodies. Overall, these observa-
tions suggest that a complex local sequence environment, in-
cluding the spatial relationship and relative distribution of both
AID and Polη cold spots and hotspots, contributes significantly
to the frequency and distribution of mutations throughout the Ig
V region. This is further supported by our biochemical studies
(Fig. 4) showing that the OHS1 and OHS2 AGCTs, and perhaps
some of the neighboring sequences, were inherently more sus-
ceptible to AID deamination even when they were presented on
single-stranded DNA to purified AID. In addition, the spatial
interplay of AID hotspots and Polη hotspots is consistent with
the functional, although not physical, interactions (63–66) be-
tween AID and MMR complexes. These considerations suggest
it is important to use actual V regions rather than artificial syn-
thetic sequences to study mechanistic issues such as the size of the
patch that is excised during MMR to remove the G:U mismatch
created by AID to introduce mutations in A:T.
Overlapping Hotspots Recruit and Regulate AID Activity to the
IGHV3-23*01 V Region. The very high frequency of mutation in
OHS2, and to a lesser degree in the other overlapping hotspots,
also suggested that in B cells expressing IGHV3-23*01, these
overlapping hotspots might be the first sites to undergo AID
mutation. It is unlikely that they are physical entry sites for the
binding of AID because biochemical studies have shown that
AID can bind equally well to single-stranded DNA that does and
does not have Cs (67, 68). However, AID is a very inefficient
enzyme deaminating only one of every 30 dCs it encounters in
hotspot motifs (57), so it is possible that the AGCTs in IGHV3-
23*01 are often the first site to be deaminated. This is consistent
with their being the most frequent site of mutation, but they
might sometimes also act as an activation site to extend AID
mutation to other sites in some V regions. We examined this
possibility for OHS2 first by separating the V regions into those
that had undergone mutation in the dC on either both strands or
either strand alone and compared them with the V regions that
had not undergone mutation in the GC in OHS2. If we ignored
the mutations that had occurred in GC in OHS2 in calculating
the frequency of mutation, those V regions that had undergone
mutations in OHS2 had 3.5 times more average mutations per V
region than in those V regions where GC in OHS2 were not
mutated and a threefold higher overall frequency of mutation
throughout the V region (Figs. 2 and 3). This was also true of the
AGCTs in OHS1 in CDR1, at 104 and 105 in CDR1, and at 9
and 10 in FW1, even though they had lower frequencies of
mutation than OHS2 (Fig. 2). The biochemical mechanism re-
sponsible for higher frequencies of mutation of AGCT is unclear,
but once this initial event occurs, it can lead to the recruitment of
noncanonical base excision repair and MMR. The resulting
frequency of mutation of A:T bases is dependent on the presence
of Polη hotspots and their proximity to other motifs.
Although these findings are consistent with the individual
AGCTs sometimes acting as an initiation or activation site, they
are merely correlations and could also reflect a different po-
tential for SHM in different B cells. For example, a memory B
cell might have come from a clone that expressed lower levels of
AID or some of its associated proteins at the time when muta-
tions were occurring, and then it would have fewer mutated V
regions. Distinguishing between these two different models is
especially difficult because it has not been possible to establish
how many mutations occur during each cell division (25, 53–55)
or to find convincing experimental evidence that AID is
processive in vivo (53). It is even possible that AID does not al-
ways behave the same way on each V region at each cell division.
For example, AID might occasionally increase its efficiency,
pause for a longer period, or remain associated with the tran-
scriptional apparatus to generate multiple mutations during a sin-
gle cell cycle to mutate more distant sites. This could occur, for
example, in B cells that go through multiple sequential divisions
in the dark zone germinal center and that undergo more muta-
tions than the majority of the B cells that shuttle back forth at
every cell division between the dark and the light zone (25).
To examine this question further, we used site-directed mu-
tagenesis to substitute neutral or cold spots for the AGCTs and
their neighboring sequences in CDR1 and CDR2 and then ex-
amined these modified sequences in a biochemical system and in
Ramos cells (Figs. 4 and 5). In the biochemical system, on the
top strand of the modified V region, there are significantly fewer
mutations elsewhere in the modified V region compared with in
the WT V region. These studies confirmed that purified AID
had a preference for the AGCT, even on single-stranded DNA.
However, it is difficult to extrapolate the in vitro findings to the
in vivo events because in the biochemical system, AID both is
E734 | www.pnas.org/cgi/doi/10.1073/pnas.1500788112 Wei et al.
limiting and is processive through a slide and jump mechanism
(56, 57). The Ramos cells provide a good cellular model for the
initial mutational events that occur in vivo because AID is
constantly expressed and the relative susceptibility of the dif-
ferent AID hotspots to mutation is similar to that seen in mice
(69). However, the frequency of AID-induced mutation is 20–
50 times lower in the Ramos cells than is estimated to occur in
vivo (4, 58–60). Because the frequency of mutation was so
much lower than in vivo and almost all of the mutated V
regions had only one mutation, it was easier to see that the
OHS2 had an ∼10 times higher frequency of mutation than the
other AGCTs and an ∼100 times higher frequency of mutation
than at many other sites in the V region (Fig. 5). When the 3-23
V regions from which the overlapping hotspots had been re-
moved were inserted into the endogenous locus in Ramos cells,
there was an approximately twofold reduction in the percentage
of V regions mutated, and the overall frequency of mutation
was significantly reduced (Fig. 6). When both OHS2 and OHS1
or only OHS2 was replaced, almost all of the loss of mutations
was restricted to the sites that had been changed. However,
there was also a significant decrease in mutation elsewhere in
the V region, which is consistent with the results of the memory
B-cell database analysis.
These studies suggest that most of the initial AID-induced
mutations in IGHV3-23*01 are the result of a largely stochastic
process that greatly favors mutations at AGCT and AGCA
overlapping hotspot motifs. The relative frequency of these
mutations depends on the motif itself and on the local sequence
environment, including the presence of other motifs. In vivo, the
initial AID-induced mutation in each of the AGCTs is associated
with greater increases in AID mutations throughout the V re-
gion. It is not clear why this effect is much greater in vivo than in
Ramos cells, but it is possible that the higher levels of AID or the
different relative expression of other factors regulated by the
germinal center environment either increase the likelihood of
AID acting processively or change the susceptibility of other
parts of the V region to mutation.
Potential Effect of the Mutations in the Overlapping Hotspots on the
Binding of Antigen. We have concluded that the V region is
a highly evolved collection of DNA motifs that allow AID and
the error-prone MMR that it recruits to preferentially mutate
parts of the V region to provide useful antibodies. The IGHV3-
23*01 germ line DNA sequence and the mutations that arise
from it in the absence of antigen selection allow us to think about
the starting point for the generation of antibodies to many dif-
ferent antigens. Examination of the crystal structure of IGHV3-
23*01 (Fig. S3) revealed that OHS2 is at the very base of CDR2
and that the alanine 50 encoded by it is in close proximity both to
the tyrosine 59, which is at the C-terminal end of CDR2, and the
serine 35, which is encoded by the overlapping hotspots at resi-
due 104 and 105, which are at the C-terminal end of CDR1. The
unselected mutations that are recorded at G in OHS2 in the
database (46) are all replacement mutations. Fifty percent of
those mutations were transitions that would create a threonine,
which, based on modeling with the Pymol program, would po-
tentially create clashing of the side chains and destabilize the
base of CDR2. The rest of the mutations are transversions that
generate a serine that would have little effect on the protein
structure or a proline that could have large effects. In addition,
65% of the mutations at residue 104, which encodes the serine in
the C-terminal end of CDR1, are transitions that would create
an alanine, and the rest are transversions that would create
a threonine or isoleucine; according to the Pymol program, these
changes could also create instability at the bases of both CDR2
and CDR1. These mutations are reminiscent of the mutations at
the bases of the CDRs in anti-HIV and anti-influenza antibodies
that have no direct contact with the antigen but change the
stability of the CDR loops in some cases, converting the anti-
bodies from affinity-matured highly neutralizing antibodies with
restricted specificity into broadly neutralizing and protective
antibodies to those viruses (1, 70, 71). The glutamine and leucine
encoded by the highly mutated AGCT at residues 9 and 10 (Fig.
S3) are interesting because this AGCT is present in many dif-
ferent human V regions and is spatially close to CDR1. According
to the Pymol program, the amino acid changes that arise there
will not affect the structure of CDR1 but could themselves be
interacting with antigen, and perhaps contribute to the docking
of the antibody. In addition, there are regions in parts of FW3
that have DNA motifs that allow them to undergo relatively
high frequencies of mutations (Fig. 1) that in other V regions
contribute to the broadly neutralizing capacity of antibodies
to HIV (1) and influenza (30) by stabilizing or modifying the
CDR structures.
In conclusion, the association of mutations with the very in-
tricate organization of various motifs in the IGHV3-23*01 region
establishes that the DNA sequence is highly evolved to determine
the frequency of AID and error-prone MMR mutations in this
particular V region. A similar analysis of other antigen selected
and unselected human V regions should reveal why different V
regions often dominate the response to different antigens and
why we need so many V regions. Our findings also suggest that
part of the process of developing new vaccine strategies should
include the identification of motifs in those V regions that are
likely to be initially be targeted AID and to use that information
in planning which antigens should be used in sequential vaccines
(1, 30, 72–74). Similar genomewide analysis could also increase
our understanding of the how AID is targeted to V and SRs and
to certain off-target sites and contributes to our understanding of
the biochemical mechanisms of these processes.
Methods
Cell Culture. The Ramos Burkitt’s lymphoma cell line with RMCE was
generated (58) and grown in Iscove’s modified Dulbecco’s medium
(BioWhittaker) supplemented with 10% (vol/vol) FBS (Atlanta Biologicals),
100 U/mL penicillin-streptomycin (Mediatech), and 0.6 mg/mL hygromycin
(Calbiochem). Soft agar cloning was performed and Ramos 6.25 subclone
was used as IgM+ control.
RMCE Replacement Plasmids Construction. The pUCVDJ1EμSμ replacement
plasmids created as described in ref. 58 were digested with AgeI and EcoRI,
and the IGHV4-34 promoter and VDJ region were cut out from the construct,
leaving behind the 2L and L3 for exchange and Eμ and Sμ region. The germ
line IGHV3-23*01 gene from promoter to J6 was amplified with primers
(forward: ATACCGGTGAGAAGTCAGGTCCAGTGGTG; reverse: GAATTCG-
GCTCCCAGATCCTCAAGGCAC) by using genomic DNA from a patient with
chronic lymphocytic leukemia provided by Nicholas Chiarozzi’s laboratory
as a template. PCR products were digested with AgeI and EcoRI and ligated
into the previously AgeI- and EcoRI-digested pUCVDJ1EμSμ, and then pUC3-
23WTEμSμ was made. The sequence-modified IGHV3-23*01 DNA fragments
(3-23Mod and 3-23AATT) were generated by site-directed mutagenesis.
The modified IGHV3-23*01 DNA fragments were digested with AgeI and
EcoRI and ligated into previously digested pUCVDJ1EμSμ, and then pUC3-
23ModEμSμ and pUC3-23AATTEμSμ were constructed.
Plasmid Transfection, Fluorescence Analysis, and Sorting. The Ramos cells with
RMCE were electroporated with replacement plasmids pUC3-23WTEμSμ,
pUC3-23ModEμSμ, and pUC3-23AATTEμSμ, as described in ref. 58. After
transfection, the Ramos cells were stained with anti-human IgM-fluorescein
isothiocyanate, and IgM-fluorescein isothiocyanate-positive cells were sorted
and subcloned by soft agar cloning and then cultured in Iscove’s modified
Dulbecco’s medium for a total of 3 mo.
In Vitro AID Deamination Assay. IGHV3-23*01 gene fragments were amplified
from a vector containing germ line IGHV3-23*01 cDNA (provided by Nicholas
Chiorazzi) by using 30 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for
1 min. The primers used were 5′-TAATGCATTTGCCTTTCTCTCCACAGGT-3′
(forward) and 5′-TAATGCATTTCGGGGAAGTAGTCCTTGA-3′ (reverse). PCR
products were cloned into the PstI site of a derivative of the M13 mp2
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phage vector described previously (75) in both orientations, with either
the top or bottom strand inserted downstream of the lacZ gene. Closed
circular DNA gapped substrates were prepared as previously described (6).
Deamination reactions using 500 ng gapped DNA substrate and GST-AID
protein purified from SF9 insect cells (6) were performed as described in ref.
75. ssDNAs from white M13 phage plaques were isolated using the QIAprep
Spin M13 Kit (Qiagen) and sequenced by using Sanger sequencing machine
and primer P7: 5′-ATGTGAGCGAGTAACAAC-3′. Deaminations were scored
by C-to-T transition mutations, as described in refs. 6 and 75. Sequences
were analyzed using the SHMtool (76). Modified IGHV3-23*01 gene frag-
ments for making the 3-23Mod M13 mp2 phage were generated by site-
direct mutagenesis and then amplified with the same primers and conditions
used for generating 3-23WT DNA fragments. The same procedures for making
the constructs and deamination analysis were used for 3-23Mod as for 3-23WT.
Ilumina Mi seq Sequencing Library Preparation. After transfection of Ramos
(RMCE) cells with replacement vectors, the transfectants were carried for
3 mo, and genomic DNAs were extracted from Ramos 1 × 106 cells using
a DNeasy kit from QIAGEN. A 360-bp fragment in the V region was amplified
using the oligonucleotides (forward: TTTGCAGGTGTCCAGTGT; reverse:
CCAGTAGTCAAAGTAGTAGATCCC) with 2 U pfu Turbo Cx Hotstart poly-
merase (Stratagene) in a 25-μL reaction under the following conditions:
94 °C for 5 min, followed by 26 cycles at 94 °C for 20 s, 60 °C for 20 s, and
72 °C for 30 s. DNA fragments were processed through successive enzymatic
treatments of end repair, dA tailing, and ligation to adapters according to
the manufacturer’s instructions (Illumina Truseq kit). The adapter contains
the barcode sequences. Adapter-ligated libraries were further amplified by
PCR with Phusion High-Fidelity DNA Polymerase (Finnzymes), using Illumina
PE primers for 10 cycles. The resulting purified DNA libraries were multi-
plexed and applied to an Illumina flow cell for cluster generation and
sequenced on the Genome Analyzer according to the manufacturer’s pro-
tocols in the Einstein Epigenetics Facility.
Analysis of Deep Sequencing Data. The 250 × 250 paired-end deep-sequenc-
ing data were analyzed using customized R scripts. Barcodes were initially
removed using the Illumina Basespace pipeline. For quality filtering, reads
with mean quality Q < 25 were removed. Within the remaining reads, in-
dividual sites with quality Q < 30 were also removed by restoring them to
the consensus. Further filtering was used to remove sequences with three or
more mismatches, which we considered unlikely to happen in Ramos, given
the usual low mutation frequencies. We found empirically that this filter
also removes almost all sequences with indels, which were not considered in
this analysis. Within the overlap region of the two paired-end reads, the
higher-quality site call was used if quality scores were different; otherwise, if
the call was also different, the site was restored to consensus.
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